Literature DB >> 28593531

Distinguishing appraisal and personality influences on quality of life in chronic illness: introducing the quality-of-life Appraisal Profile version 2.

Bruce D Rapkin1, Iliana Garcia1, Wesley Michael2, Jie Zhang3, Carolyn E Schwartz4,5.   

Abstract

BACKGROUND: Cognitive appraisal of quality of life (QOL) differs across individuals in ways that explain otherwise paradoxical findings, such as similar QOL ratings among individuals in highly divergent health states. Although warranted by a growing body of evidence, routine assessment of appraisal in QOL research has been impeded by measurement challenges. This study describes the QOL Appraisal Profile-version 2 (QOLAPv2), a new measure that addresses these challenges.
METHODS: A heterogeneous, on-line cohort of chronic disease patients and caregivers completed the QOLAPv2, along with demographics, PROMIS10 and Brief NEO Personality Inventory (NEO-PI). Analyses address the psychometric properties and construct validity of this new measure using principal components, bivariate, canonical correlation, and linear regression analyses.
RESULTS: Analysis including 4173 respondents yielded 12 second-order QOLAPv2 principal components. Appraisal components varied with age and disease duration. Appraisals involving "Wellness," "Health," and "Recent Challenges" were correlated with QOL and with NEO-PI scales of "Agreeableness" and "Conscientiousness." Canonical correlation analysis revealed that QOL scales were associated with appraisals involving "Spirituality," "Anticipating Decline," and "Lightness of Being." Appraisal dimensions of "Relationships," "Maintaining Roles," "Independence," "Pursuing Dreams," and "Lightness of Being" were also associated with personality scales. Appraisal measures accounted for significantly more variance in QOL than personality and demographics alone.
CONCLUSIONS: Findings corroborate the Rapkin and Schwartz QOL appraisal theory. QOL appraisal measures correlate as expected with personality scales, and explain more variance in QOL than does personality. The QOLAPv2 can be used across populations to provide insight into patients' concerns, salient experiences, and comparators.

Entities:  

Keywords:  Appraisal; Chronic disease; Cognitive processes; Patient-reported outcomes; Personality; Quality of life; Rare disease; Response shift

Mesh:

Year:  2017        PMID: 28593531     DOI: 10.1007/s11136-017-1600-y

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  18 in total

Review 1.  The clinical significance of adaptation to changing health: a meta-analysis of response shift.

Authors:  Carolyn E Schwartz; Rita Bode; Nicholas Repucci; Janine Becker; Mirjam A G Sprangers; Peter M Fayers
Journal:  Qual Life Res       Date:  2006-09-26       Impact factor: 4.147

2.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

3.  How should we define health?

Authors:  Machteld Huber; J André Knottnerus; Lawrence Green; Henriëtte van der Horst; Alejandro R Jadad; Daan Kromhout; Brian Leonard; Kate Lorig; Maria Isabel Loureiro; Jos W M van der Meer; Paul Schnabel; Richard Smith; Chris van Weel; Henk Smid
Journal:  BMJ       Date:  2011-07-26

Review 4.  Appraisal assessment in patient-reported outcome research: methods for uncovering the personal context and meaning of quality of life.

Authors:  Carolyn E Schwartz; Joel A Finkelstein; Bruce D Rapkin
Journal:  Qual Life Res       Date:  2016-12-17       Impact factor: 4.147

5.  Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing.

Authors:  Richard C Gershon; Jin Shei Lai; Rita Bode; Seung Choi; Claudia Moy; Tom Bleck; Deborah Miller; Amy Peterman; David Cella
Journal:  Qual Life Res       Date:  2011-08-27       Impact factor: 4.147

6.  Classification and regression tree uncovered hierarchy of psychosocial determinants underlying quality-of-life response shift in HIV/AIDS.

Authors:  Yuelin Li; Bruce Rapkin
Journal:  J Clin Epidemiol       Date:  2009-11       Impact factor: 6.437

7.  Case management poststroke did not induce response shift: the value of residuals.

Authors:  Nancy E Mayo; Susan C Scott; Sara Ahmed
Journal:  J Clin Epidemiol       Date:  2009-11       Impact factor: 6.437

Review 8.  Psychological well-being revisited: advances in the science and practice of eudaimonia.

Authors:  Carol D Ryff
Journal:  Psychother Psychosom       Date:  2013-11-19       Impact factor: 17.659

9.  Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology.

Authors:  D Cella; J-S Lai; C J Nowinski; D Victorson; A Peterman; D Miller; F Bethoux; A Heinemann; S Rubin; J E Cavazos; A T Reder; R Sufit; T Simuni; G L Holmes; A Siderowf; V Wojna; R Bode; N McKinney; T Podrabsky; K Wortman; S Choi; R Gershon; N Rothrock; C Moy
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

10.  Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal.

Authors:  Carolyn E Schwartz; Bruce D Rapkin
Journal:  Health Qual Life Outcomes       Date:  2004-03-23       Impact factor: 3.186

View more
  8 in total

1.  Development of a practical outcome measure to account for individual differences in quality-of-life appraisal: the Brief Appraisal Inventory.

Authors:  Bruce D Rapkin; Iliana Garcia; Wesley Michael; Jie Zhang; Carolyn E Schwartz
Journal:  Qual Life Res       Date:  2017-11-10       Impact factor: 4.147

2.  Resilience to health challenges is related to different ways of thinking: mediators of physical and emotional quality of life in a heterogeneous rare-disease cohort.

Authors:  Carolyn E Schwartz; Wesley Michael; Bruce D Rapkin
Journal:  Qual Life Res       Date:  2017-06-28       Impact factor: 4.147

3.  Testing for response shift in treatment evaluation of change in self-reported psychopathology amongst secondary psychiatric care outpatients.

Authors:  Ingrid V E Carlier; Wessel A van Eeden; Kim de Jong; Erik J Giltay; Martijn S van Noorden; Christina van der Feltz-Cornelis; Frans G Zitman; Henk Kelderman; Albert M van Hemert
Journal:  Int J Methods Psychiatr Res       Date:  2019-06-17       Impact factor: 4.035

4.  Response-shift effects in neuromyelitis optica spectrum disorder: a secondary analysis of clinical trial data.

Authors:  Carolyn E Schwartz; Roland B Stark; Brian D Stucky
Journal:  Qual Life Res       Date:  2020-12-02       Impact factor: 4.147

5.  Siblings' life aspirations in the context of Duchenne muscular dystrophy: a mixed-methods case-control study.

Authors:  Carolyn E Schwartz; Elijah Biletch; Richard B B Stuart; Bruce D Rapkin
Journal:  J Patient Rep Outcomes       Date:  2022-09-10

6.  Patient life aspirations in the context of Duchenne Muscular Dystrophy: a mixed-methods case-control study.

Authors:  Carolyn E Schwartz; Elijah Biletch; Richard B B Stuart; Bruce D Rapkin
Journal:  J Patient Rep Outcomes       Date:  2022-09-14

7.  The minimal perceived change: a formal model of the responder definition according to the patient's meaning of change for patient-reported outcome data analysis and interpretation.

Authors:  Antoine Vanier; Véronique Sébille; Myriam Blanchin; Jean-Benoit Hardouin
Journal:  BMC Med Res Methodol       Date:  2021-06-21       Impact factor: 4.615

8.  What should progress in response-shift research look like?

Authors:  Bruce D Rapkin; Carolyn E Schwartz
Journal:  Qual Life Res       Date:  2021-07-30       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.